Sub Banner Default Image
Home / Jobs /

Evidence Generation Learning Lead

Evidence Generation Learning Lead

Back to job search

Evidence Generation Learning Lead

  • Location:

    Brussels

  • Sector:

    Technical Operations - Pharma

  • Contact:

    Harry Reeve

  • Salary:

    €60 - €87 per hour

  • Job type:

    Interim/Contract

  • Contact email:

    harry.reeve@msipharma.com

  • Job ref:

    HRIT260777A_1716889319

  • Published:

    28 days ago

  • Duration:

    12 Months

  • Startdate:

    ASAP

MSI Pharma are working with a leading pharmaceutical company in Belgium who are looking for a Learning Lead to join their team.

Are you passionate about evidence generation and transforming the biopharmaceutical industry? We're seeking a Learning and Development Lead for Evidence Generation. You'll design and implement a global competency-based learning journey, addressing key skill gaps aligned with Integrated Evidence Generation (ISEG) Lead roles. Collaborate with stakeholders to deliver tailored learning solutions supporting a culture change for 's ambition in evidence generation.

RESPONSIBILITIES

Devise and execute an integrated competency-based learning journey. Curate learning content with subject matter experts, ensuring a comprehensive curriculum for various skill levels. Collaborate with partners, leaders, and teams, managing the end-to-end learning delivery process. Evaluate learner impact, gather feedback, and use analytics for continuous improvement.

EDUCATION & QUALIFICATION

Bachelor's Degree Minimum 5 years' experience in health sciences, evidence generation, or related fields. Strong knowledge of learning principles, instructional design, and technologies. Excellent communication and project management skills.

COMPETENCIES

Leadership skills to drive continuous learning. Effective communication for conveying complex ideas. Strong analytical thinking for assessing learning needs. Innovative mindset for introducing new methodologies. Proven collaboration skills with diverse stakeholders.